RxDoctor Payments Data

Dzi-Viet Nguyen, DO

Hand Surgery · St Petersburg, FLNPI 1265698294

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.1%), speaking fees and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Tulavi Therapeutics, Inc. at 38.6% of the total. 2025 is the largest year on record at $6,192, 6.7 times the $925 reported in 2019.

$12,347in general payments, 2019–2025

Across 165 payments — averaging $74.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tulavi Therapeutics, Inc.$5K
  • Acumed LLC$1K
  • Smith+Nephew$1K
  • MVP Orthopedics Inc$850
  • Axogen$821
  • Arthrex$700
  • plus $2K from 24 others

What the payments were for

  • Speaking & faculty fees$4,00032%
  • Food & beverage$6,79855%
  • Education$1,52012%
  • Entertainment$280%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,347 in reported general payments places this provider in the 80th percentile of 173 hand surgery providers in Florida.

See all hand surgery providers in Florida

Medicare billing

Part B allowed, 2024
$435,333
Medicare patients
729
Services billed
12,130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron350$7,076
Ibuprofen361$3,653
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen276$3,075
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen206$2,548
Cephalexin305$1,594
Naproxen127$1,075
Cyclobenzaprine Hcl73$913
Doxycycline Hyclate32$332
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim72$324
Tramadol Hcl47$214
Gabapentin27$195
Mupirocin14$111
Meloxicam45$94
Methylprednisolone11$90

Paid to pharmacies, not to this prescriber.

Other hand surgery in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →